Skip to content

Psilocybin as a healer

Kavita Golia

Consciousness, Spirituality & Transpersonal Psychology September 12, 2022 DOI: 10.53074/cstp.2022.37 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Qualitative study Peer reviewed
Sample size 12
Population Individuals who microdose psilocybin
Intervention psilocybin microdosing
Dose sub-perceptual amount
Topics Psilocybin
Keywords Creativity Mental health Feeling Perception Lived experience Psychotherapist Clinical psychology Hallucinogen
Citations 1
Key findings Seven themes emerged from the lived experiences of psilocybin microdosing, including improvements in mental health, wellbeing, productivity, and creativity for those with a musical background.

Abstract

This phenomenological research explored the fast-growing societal trend in psilocybin microdosing, whereby a sub-perceptual amount of the psychedelic is consumed regularly. Anecdotal reports of microdosing have suggested that individuals can experience the relief of depressive symptoms, greater creativity and focus, deeper connections, and improvements in several mental health issues. Research on the lived experience of psilocybin microdosing, however, is lacking. Semi-structured interviews were conducted with 12 individuals to explore their lived experiences of microdosing. Seven central themes were observed in most individuals: 1) Mental Health; 2) Dose effects; 3) A feeling of connection to self, nature, or something ‘bigger’; 4) An increase in productivity; 5) An increased state of wellbeing; 6) Navigating problems more effectively; 7) Participants with a musical background experienced an increase in their levels of creativity. By providing support for the use of psilocybin microdosing, the findings are valuable in the growing field of psychedelic research. However, as these purported benefits are based on self-reports, further controlled studies are necessary.

Comparable studies

Other qualitative studies on psilocybin, most cited first.

Study Year Design Participants
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression enrolled in an open-label trial of psilocybin 2017 Qualitative study n = 20
Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis Adults aged 22 to 69 with clinically elevated anxiety associated with a cancer diagnosis 2017 Qualitative study n = 13
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts Participants who completed a psilocybin-facilitated smoking cessation pilot study 2018 Qualitative follow-up study using semi-structured interviews and thematic analysis n = 12
Response of cluster headache to psilocybin and LSD Cluster headache patients who used psilocybin or LSD 2006 Qualitative study n = 53
Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress Adult participants with clinically elevated anxiety associated with a cancer diagnosis 2017 Qualitative study using interpretative phenomenological analysis n = 13

Citations in the library

Explore topics